Extranigral neurodegeneration in Parkinson's disease: A role for calpain in neurodegeneration

Annals of the New York Academy of Sciences

Volumn 1139, Issue , 2008, Pages 331-336

  Samantaray, Supriti ^a   Butler, Jonathan T ^a   Ray, Swapan K ^b   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Calpain; MPTP; Parkinson's disease; Rotenone; Spinal cord; VSC 4.1 cells

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CALPAIN; CALPEPTIN; ROTENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; ENZYME INHIBITION; INFLAMMATION; MESENCEPHALON; MOTONEURON; MOTOR COORDINATION; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; SPINAL CORD ATROPHY; SUBSTANTIA NIGRA;

PARKINSONIA;

EID: 53549091611     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1432.002     Document Type: Conference Paper

References (18)

1. Dauer, W. & S. Przedborski. 2003. Parkinson's disease: mechanisms and models. Neuron 39 : 889 909.
2. Bloch, A. et al. 2006. α-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol. Appl. Neurobiol. 32 : 284 295.
3. Klos, K.J. et al. 2006. α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology 66 : 1100 1102.
4. Martin, L.J. et al. 2006. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26 : 41 50.
5. Samantaray, S. et al. 2007. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP. J. Neurochem. 104 : 1309 1320.
6. Samantaray, S. et al. 2007. The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience 146 : 741 755.
7. Samantaray, S. et al. 2006. Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism. Ann. N. Y. Acad. Sci. 1074 : 349 356.
8. Braak, H. et al. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging. 24 : 197 211.
9. Braak, H. et al. 2004. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318 : 121 134.
10. Mitchell, I.J. et al. 1985. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus. Neurosci. Lett. 61 : 195 200.
11. Seniuk, N.A., W.G. Tatton & C.E. Greenwood. 1990. Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP. Brain Res. 527 : 7 20.
12. Freyaldenhoven, T.E., S.F. Ali & L.C. Schmued. 1997. Systemic administration of MPTP induces thalamic neuronal degeneration in mice. Brain Res. 759 : 9 17.
13. Betarbet, R. et al. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 : 1301 1306.
14. Ray, S.K. & N.L. Banik. 2003. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 2 : 173 189.
15. Mouatt-Prigent, A. et al. 1996. Increased m-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience 73 : 979 987.
16. Crocker, S.J. et al. 2003. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J. Neurosci. 23 : 4081 4091.
17. Chen, M.J. et al. 2006. Early induction of calpains in rotenone-mediated neuronal apoptosis. Neurosci. Lett. 397 : 69 73.
18. Chera, B. et al. 2004. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mice. Brain Res. 1006 : 150 156.